18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and SurvivalGiulia Polverari, Désirèe Deandreis, Francesco Ceci et al.|Cancers|2020Cited by 97
68Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapyDésirèe Deandreis, Paolo Gontero, Francesco Ceci et al.|European Journal of Nuclear Medicine and Molecular Imaging|2020Cited by 39
Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapyFrancesco Ceci, Désirèe Deandreis, Guido Rovera et al.|European Journal of Nuclear Medicine and Molecular Imaging|2022Cited by 26
[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trialGiulia Polverari, Noah Federman, Francesco Ceci et al.|EJNMMI Research|2020Cited by 15
Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced MelanomaVirginia Liberini, Désirèe Deandreis, Marco Rubatto et al.|Journal of Clinical Medicine|2021Cited by 5